Shanghai Medicilon Inc Asset Resilience Ratio

Latest as of June 2026: 6.69%

Shanghai Medicilon Inc asset resilience ratio. Shanghai Medicilon Inc (688202) has an Asset Resilience Ratio of 6.69% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shanghai Medicilon Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥192.85 Million

≈ $28.22 Million USD Cash + Short-term Investments

Total Assets

CN¥2.88 Billion

≈ $421.57 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Shanghai Medicilon Inc (2021–2025)

Asset resilience ratio of Shanghai Medicilon Inc from 2021 to 2025. This chart shows how Shanghai Medicilon Inc's Asset Resilience Ratio has changed over time. Read 688202 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Medicilon Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shanghai Medicilon Inc balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥192.85 Million	6.69%
Total Liquid Assets	CN¥192.85 Million	6.69%

Asset Resilience Insights

Limited Liquidity: Shanghai Medicilon Inc maintains only 6.69% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Medicilon Inc Industry Peers by Asset Resilience Ratio

Compare Shanghai Medicilon Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Shanghai Medicilon Inc Asset Resilience Ratio by Year (2021–2025)

Shanghai Medicilon Inc asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Shanghai Medicilon Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.33%	CN¥113.41 Million ≈ $16.59 Million	CN¥2.62 Billion ≈ $383.69 Million	-4.93pp
2024-12-31	9.25%	CN¥261.22 Million ≈ $38.23 Million	CN¥2.82 Billion ≈ $413.13 Million	-6.62pp
2023-12-31	15.87%	CN¥518.23 Million ≈ $75.83 Million	CN¥3.27 Billion ≈ $477.90 Million	+10.29pp
2021-12-31	5.58%	CN¥100.00 Million ≈ $14.63 Million	CN¥1.79 Billion ≈ $262.46 Million	--

pp = percentage points

About Shanghai Medicilon Inc

SHG:688202 China Biotechnology

Market Cap

$1.46 Billion

CN¥9.99 Billion CNY

Market Cap Rank

#7064 Global

#1462 in China

Share Price

CN¥74.38

Change (1 day)

-5.97%

52-Week Range

CN¥51.31 - CN¥117.08

All Time High

CN¥394.88